Genomics Market By Product , By Technology By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

Genomics Market

The genomics market was valued at $33.2 billion in 2023 and is projected to reach $97.1 billion by 2033, growing at a CAGR of 11.5% from 2024 to 2033.

Genomics is the branch of molecular biology that involves the study of structure, function, mapping, evolution, and editing of the genome of living organisms. A genome is defined as the entire set of an individual's deoxyribonucleic acid (DNA). DNA is an essential chemical compound present inside a living body that contains the critical information for the development and functioning of the body. The major role of genomics is to determine the sequence of molecules which form the DNA content of organisms.

Increase in the integration of genomics into healthcare through personalized treatment plans, diagnosis of diseases, and genetic testing is driving the development of the market. In addition, constant efforts toward new drug development are boosting the demand for innovative genomics technology. In recent times, 3D and spatial genomics is a flourishing trend that involves studying the spatial positioning of chromatin inside the nucleus. This technology is predicted to revolutionize the field of human health and medicine owing to the novel insights it provides into the genetic makeup of individuals.

However, the high expense of establishing genomics laboratories and infrastructure acts as a key restraint for the growth of the market. In addition, the high risk associated with the misuse of genetic data limits market development. According to an article by the National Center for Biotechnology Information, every year millions of individuals dynamically provide unlimited access of their health information to different institutions for multiple uses, including insurance and commercial transactions. The sharing of data is highly extensive such that the information becomes available to institutions not covered under Health Insurance Portability and Accountability Act (HIPPA), thereby losing the security offered by the HIPAA Privacy Rule.

Segment Review

The genomics market is segmented into product, technology, application, end user, and region. On the basis of product, the market is divided into consumables & reagent, services, instruments, systems and software. By technology, it is classified into sequencing, PCR, flow cytometry, microarray, and others. As per application, it is categorized into functional genomics, epigenomics, pathway analysis, biomarker discovery, and others. Depending on end user, it is segmented into clinical research, academic & government institutions, hospitals & clinics, pharmaceutical & biotechnology companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the consumables & reagent segment dominated the market in 2023.

By technology, the sequencing segment held the highest market share in 2023.

As per application, the functional genomics segment acquired a high stake in the market in 2023.

Depending on end user, the pharmaceutical & biotechnology companies segment was the highest shareholder in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global genomics market include Color Genomics, Inc., BGI Genomics, Agilent Technologies, Danaher Corporation, Eppendorf AG, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., and Bio-Rad Laboratories, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Average Selling Price Analysis / Price Point Analysis
Criss-cross segment analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Market share analysis of players at global/region/country level

Key Market Segments

By Product

Consumables and Reagent
Services
Instruments, Systems and Software

By Technology

Sequencing
PCR
Flow Cytometry
Microarray
Others

By Application

Functional Genomics
Epigenomics
Pathway Analysis
Biomarker Discovery
Others

By End User

Clinical Research
Academic and Government Institutions
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- UAE
- Rest of LAMEA

Key Market Players:

Color Genomics, Inc.
BGI Genomics
Agilent Technologies
Danaher Corporation
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
GE Healthcare
Illumina, Inc.
Bio-Rad Laboratories, Inc.

Product Code: A05109

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: GENOMICS MARKET, BY PRODUCT

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
4.2. Consumables And Reagent
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Services
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Instruments, Systems And Software
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country

CHAPTER 5: GENOMICS MARKET, BY TECHNOLOGY

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Technology
5.2. Sequencing
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. PCR
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Flow Cytometry
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
5.5. Microarray
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
5.6. Others
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country

CHAPTER 6: GENOMICS MARKET, BY APPLICATION

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Application
6.2. Functional Genomics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Epigenomics
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Pathway Analysis
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
6.5. Biomarker Discovery
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
6.6. Others
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country

CHAPTER 7: GENOMICS MARKET, BY END USER

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By End User
7.2. Clinical Research
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
7.3. Academic And Government Institutions
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
7.4. Hospitals And Clinics
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country
7.5. Pharmaceutical And Biotechnology Companies
- 7.5.1. Key Market Trends, Growth Factors and Opportunities
- 7.5.2. Market Size and Forecast, By Region
- 7.5.3. Market Share Analysis, By Country
7.6. Others
- 7.6.1. Key Market Trends, Growth Factors and Opportunities
- 7.6.2. Market Size and Forecast, By Region
- 7.6.3. Market Share Analysis, By Country

CHAPTER 8: GENOMICS MARKET, BY REGION

8.1. Market Overview
- 8.1.1 Market Size and Forecast, By Region
8.2. North America
- 8.2.1. Key Market Trends and Opportunities
- 8.2.2. Market Size and Forecast, By Product
- 8.2.3. Market Size and Forecast, By Technology
- 8.2.4. Market Size and Forecast, By Application
- 8.2.5. Market Size and Forecast, By End User
- 8.2.6. Market Size and Forecast, By Country
- 8.2.7. U.S. Genomics Market
  - 8.2.7.1. Market Size and Forecast, By Product
  - 8.2.7.2. Market Size and Forecast, By Technology
  - 8.2.7.3. Market Size and Forecast, By Application
  - 8.2.7.4. Market Size and Forecast, By End User
- 8.2.8. Canada Genomics Market
  - 8.2.8.1. Market Size and Forecast, By Product
  - 8.2.8.2. Market Size and Forecast, By Technology
  - 8.2.8.3. Market Size and Forecast, By Application
  - 8.2.8.4. Market Size and Forecast, By End User
- 8.2.9. Mexico Genomics Market
  - 8.2.9.1. Market Size and Forecast, By Product
  - 8.2.9.2. Market Size and Forecast, By Technology
  - 8.2.9.3. Market Size and Forecast, By Application
  - 8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
- 8.3.1. Key Market Trends and Opportunities
- 8.3.2. Market Size and Forecast, By Product
- 8.3.3. Market Size and Forecast, By Technology
- 8.3.4. Market Size and Forecast, By Application
- 8.3.5. Market Size and Forecast, By End User
- 8.3.6. Market Size and Forecast, By Country
- 8.3.7. France Genomics Market
  - 8.3.7.1. Market Size and Forecast, By Product
  - 8.3.7.2. Market Size and Forecast, By Technology
  - 8.3.7.3. Market Size and Forecast, By Application
  - 8.3.7.4. Market Size and Forecast, By End User
- 8.3.8. Germany Genomics Market
  - 8.3.8.1. Market Size and Forecast, By Product
  - 8.3.8.2. Market Size and Forecast, By Technology
  - 8.3.8.3. Market Size and Forecast, By Application
  - 8.3.8.4. Market Size and Forecast, By End User
- 8.3.9. Italy Genomics Market
  - 8.3.9.1. Market Size and Forecast, By Product
  - 8.3.9.2. Market Size and Forecast, By Technology
  - 8.3.9.3. Market Size and Forecast, By Application
  - 8.3.9.4. Market Size and Forecast, By End User
- 8.3.10. Spain Genomics Market
  - 8.3.10.1. Market Size and Forecast, By Product
  - 8.3.10.2. Market Size and Forecast, By Technology
  - 8.3.10.3. Market Size and Forecast, By Application
  - 8.3.10.4. Market Size and Forecast, By End User
- 8.3.11. UK Genomics Market
  - 8.3.11.1. Market Size and Forecast, By Product
  - 8.3.11.2. Market Size and Forecast, By Technology
  - 8.3.11.3. Market Size and Forecast, By Application
  - 8.3.11.4. Market Size and Forecast, By End User
- 8.3.12. Rest of Europe Genomics Market
  - 8.3.12.1. Market Size and Forecast, By Product
  - 8.3.12.2. Market Size and Forecast, By Technology
  - 8.3.12.3. Market Size and Forecast, By Application
  - 8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
- 8.4.1. Key Market Trends and Opportunities
- 8.4.2. Market Size and Forecast, By Product
- 8.4.3. Market Size and Forecast, By Technology
- 8.4.4. Market Size and Forecast, By Application
- 8.4.5. Market Size and Forecast, By End User
- 8.4.6. Market Size and Forecast, By Country
- 8.4.7. China Genomics Market
  - 8.4.7.1. Market Size and Forecast, By Product
  - 8.4.7.2. Market Size and Forecast, By Technology
  - 8.4.7.3. Market Size and Forecast, By Application
  - 8.4.7.4. Market Size and Forecast, By End User
- 8.4.8. Japan Genomics Market
  - 8.4.8.1. Market Size and Forecast, By Product
  - 8.4.8.2. Market Size and Forecast, By Technology
  - 8.4.8.3. Market Size and Forecast, By Application
  - 8.4.8.4. Market Size and Forecast, By End User
- 8.4.9. India Genomics Market
  - 8.4.9.1. Market Size and Forecast, By Product
  - 8.4.9.2. Market Size and Forecast, By Technology
  - 8.4.9.3. Market Size and Forecast, By Application
  - 8.4.9.4. Market Size and Forecast, By End User
- 8.4.10. South Korea Genomics Market
  - 8.4.10.1. Market Size and Forecast, By Product
  - 8.4.10.2. Market Size and Forecast, By Technology
  - 8.4.10.3. Market Size and Forecast, By Application
  - 8.4.10.4. Market Size and Forecast, By End User
- 8.4.11. Australia Genomics Market
  - 8.4.11.1. Market Size and Forecast, By Product
  - 8.4.11.2. Market Size and Forecast, By Technology
  - 8.4.11.3. Market Size and Forecast, By Application
  - 8.4.11.4. Market Size and Forecast, By End User
- 8.4.12. Rest of Asia-Pacific Genomics Market
  - 8.4.12.1. Market Size and Forecast, By Product
  - 8.4.12.2. Market Size and Forecast, By Technology
  - 8.4.12.3. Market Size and Forecast, By Application
  - 8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
- 8.5.1. Key Market Trends and Opportunities
- 8.5.2. Market Size and Forecast, By Product
- 8.5.3. Market Size and Forecast, By Technology
- 8.5.4. Market Size and Forecast, By Application
- 8.5.5. Market Size and Forecast, By End User
- 8.5.6. Market Size and Forecast, By Country
- 8.5.7. Brazil Genomics Market
  - 8.5.7.1. Market Size and Forecast, By Product
  - 8.5.7.2. Market Size and Forecast, By Technology
  - 8.5.7.3. Market Size and Forecast, By Application
  - 8.5.7.4. Market Size and Forecast, By End User
- 8.5.8. South Africa Genomics Market
  - 8.5.8.1. Market Size and Forecast, By Product
  - 8.5.8.2. Market Size and Forecast, By Technology
  - 8.5.8.3. Market Size and Forecast, By Application
  - 8.5.8.4. Market Size and Forecast, By End User
- 8.5.9. Saudi Arabia Genomics Market
  - 8.5.9.1. Market Size and Forecast, By Product
  - 8.5.9.2. Market Size and Forecast, By Technology
  - 8.5.9.3. Market Size and Forecast, By Application
  - 8.5.9.4. Market Size and Forecast, By End User
- 8.5.10. UAE Genomics Market
  - 8.5.10.1. Market Size and Forecast, By Product
  - 8.5.10.2. Market Size and Forecast, By Technology
  - 8.5.10.3. Market Size and Forecast, By Application
  - 8.5.10.4. Market Size and Forecast, By End User
- 8.5.11. Rest of LAMEA Genomics Market
  - 8.5.11.1. Market Size and Forecast, By Product
  - 8.5.11.2. Market Size and Forecast, By Technology
  - 8.5.11.3. Market Size and Forecast, By Application
  - 8.5.11.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

10.1. Color Genomics, Inc.
- 10.1.1. Company Overview
- 10.1.2. Key Executives
- 10.1.3. Company Snapshot
- 10.1.4. Operating Business Segments
- 10.1.5. Product Portfolio
- 10.1.6. Business Performance
- 10.1.7. Key Strategic Moves and Developments
10.2. BGI Genomics
- 10.2.1. Company Overview
- 10.2.2. Key Executives
- 10.2.3. Company Snapshot
- 10.2.4. Operating Business Segments
- 10.2.5. Product Portfolio
- 10.2.6. Business Performance
- 10.2.7. Key Strategic Moves and Developments
10.3. Agilent Technologies
- 10.3.1. Company Overview
- 10.3.2. Key Executives
- 10.3.3. Company Snapshot
- 10.3.4. Operating Business Segments
- 10.3.5. Product Portfolio
- 10.3.6. Business Performance
- 10.3.7. Key Strategic Moves and Developments
10.4. Danaher Corporation
- 10.4.1. Company Overview
- 10.4.2. Key Executives
- 10.4.3. Company Snapshot
- 10.4.4. Operating Business Segments
- 10.4.5. Product Portfolio
- 10.4.6. Business Performance
- 10.4.7. Key Strategic Moves and Developments
10.5. Eppendorf AG
- 10.5.1. Company Overview
- 10.5.2. Key Executives
- 10.5.3. Company Snapshot
- 10.5.4. Operating Business Segments
- 10.5.5. Product Portfolio
- 10.5.6. Business Performance
- 10.5.7. Key Strategic Moves and Developments
10.6. Eurofins Scientific SE
- 10.6.1. Company Overview
- 10.6.2. Key Executives
- 10.6.3. Company Snapshot
- 10.6.4. Operating Business Segments
- 10.6.5. Product Portfolio
- 10.6.6. Business Performance
- 10.6.7. Key Strategic Moves and Developments
10.7. F. Hoffmann-La Roche Ltd.
- 10.7.1. Company Overview
- 10.7.2. Key Executives
- 10.7.3. Company Snapshot
- 10.7.4. Operating Business Segments
- 10.7.5. Product Portfolio
- 10.7.6. Business Performance
- 10.7.7. Key Strategic Moves and Developments
10.8. GE Healthcare
- 10.8.1. Company Overview
- 10.8.2. Key Executives
- 10.8.3. Company Snapshot
- 10.8.4. Operating Business Segments
- 10.8.5. Product Portfolio
- 10.8.6. Business Performance
- 10.8.7. Key Strategic Moves and Developments
10.9. Illumina, Inc.
- 10.9.1. Company Overview
- 10.9.2. Key Executives
- 10.9.3. Company Snapshot
- 10.9.4. Operating Business Segments
- 10.9.5. Product Portfolio
- 10.9.6. Business Performance
- 10.9.7. Key Strategic Moves and Developments
10.10. Bio-Rad Laboratories, Inc.
- 10.10.1. Company Overview
- 10.10.2. Key Executives
- 10.10.3. Company Snapshot
- 10.10.4. Operating Business Segments
- 10.10.5. Product Portfolio
- 10.10.6. Business Performance
- 10.10.7. Key Strategic Moves and Developments